Global /India /Healthcare /Drug Manufacturers - Specialty & Generic /540737
chevron_leftBack

Shree Ganesh Remedies Ltd.

540737
BSE: 540737 Delayed
767.50INR -0.8%
8.98 USD
As of 24 April 2025, Shree Ganesh Remedies Ltd. has a market cap of $115.34M USD, ranking #19941 globally and #1400 in India. It ranks #1980 in the Healthcare sector, and #452 in the Drug Manufacturers - Specialty & Generic industry.
Global Rank
19941
Country Rank
1400
Sector Rank
1980
Industry Rank
452
Key Stats
Market Cap
$115.34MUSD
9.85B INR
Enterprise Value
$116.71MUSD
9.98B INR
Revenue (TTM)
$14.28MUSD
1.22B INR
EBITDA (TTM)
$5.34MUSD
456.8M INR
Net Income (TTM)
$3.33MUSD
284.69M INR
EBITDA Margin
37%
Profit Margin
23%
PE Ratio
34.6
Company Profile
Country (HQ)
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Chandulal Kothia open_in_new
Employees
139
Founded
1995
Website
ganeshremedies.com open_in_new
warningChart data may be delayed
1d 1w 1m 3m 6m 1y
-0.8% 4.8% 2.2% 5.4% -7.9% 19%
Upcoming Earnings
Earnings Date
Fri, May 30

Markets

Exchange Ticker Price
Bombay Stock Exchange
MIC: XBOM
PRIMARY
540737 (SGRL)
Shree Ganesh Remedies Ltd Ordinary Shares
ISIN: INE414Y01015
Shares Out.:
12.835M1 Shares Float: 3.11M2
TV:
SA:
YF:
GF:
BA:
MS:
767.50 INR
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.

About Shree Ganesh Remedies Ltd.

Shree Ganesh Remedies Limited engages in the manufacture and sale of pharmaceutical drug intermediates for active pharmaceutical ingredient (API) and fine chemicals in India. It provides anti-arrhythmic, anti-cancer, anti-depressant, anti-diabetic, anti-diarrheal, anti-fungal, anti-histamine, anti-inflammatory, anti-parasitic, anti-psychotic, anticholinergic, birth-control, cardiovascular, gastrointestinal, neurological disorder, ophthalmic, opioid, and veterinary API intermediates. The company also offers fine and specialty chemicals, such as agro-chemicals, electronics, flavor and fragrance, life-sciences, and polymer chemicals, as well as other specialty chemicals, including cyclopropanecarboxaldehyde, hexamethylendichloride, octamethylendiamine, and suberonitrile for pharmaceutical, agricultural, and various chemical applications. In addition, it is involved in customized chemistry development and manufacturing; assets and infrastructure; and customized process of pharmaceutical chemicals. The company also exports its products. It serves various industries, including pharmaceuticals, biotechnology, medical devices, and others. The company was incorporated in 1995 and is headquartered in Ankleshwar, India.

Similar Companies

Industry: Drug Manufacturers - Specialty & Generic (India)
Name
Market Cap diff.
Sun Pharmaceutical Industries Ltd.
SUNPHARMA
$49.08B
4.19T INR
42K%
Divi's Laboratories Ltd.
DIVISLAB
$18.37B
1.57T INR
16K%
Cipla Ltd.
CIPLA
$14.45B
1.23T INR
12K%
Torrent Pharmaceuticals Ltd.
TORNTPHARM
$13.21B
1.13T INR
11K%
Mankind Pharma Ltd.
MANKIND
$12.46B
1.06T INR
11K%
Industry: Drug Manufacturers - Specialty & Generic (Global)
Name
Market Cap diff.
Zoetis Inc.
ZTS
$67.32B
58K%
Merck KGaA
MRK
$59.42B
52.43B EUR
51K%
Takeda Pharmaceutical Company Ltd.
4502
$46.31B
6.6T JPY
40K%
Haleon plc
HLN
$45.57B
34.34B GBP
39K%
Galderma Group AG
GALD
$23.06B
19.13B CHF
20K%